239 related articles for article (PubMed ID: 23283306)
1. Respiratory syncytial virus infection: from biology to therapy: a perspective.
Mohapatra SS; Lockey RF
World Allergy Organ J; 2008 Feb; 1(2):21-8. PubMed ID: 23283306
[TBL] [Abstract][Full Text] [Related]
2. Biological challenges and technological opportunities for respiratory syncytial virus vaccine development.
Graham BS
Immunol Rev; 2011 Jan; 239(1):149-66. PubMed ID: 21198670
[TBL] [Abstract][Full Text] [Related]
3. Impairment of T cell immunity by the respiratory syncytial virus: targeting virulence mechanisms for therapy and prophylaxis.
González PA; Bueno SM; Riedel CA; Kalergis AM
Curr Med Chem; 2009; 16(34):4609-25. PubMed ID: 19903147
[TBL] [Abstract][Full Text] [Related]
4. Mucosal Delivery of Recombinant Vesicular Stomatitis Virus Vectors Expressing Envelope Proteins of Respiratory Syncytial Virus Induces Protective Immunity in Cotton Rats.
Binjawadagi B; Ma Y; Binjawadagi R; Brakel K; Harder O; Peeples M; Li J; Niewiesk S
J Virol; 2021 Feb; 95(6):. PubMed ID: 33408176
[TBL] [Abstract][Full Text] [Related]
5. Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine Development.
Boyoglu-Barnum S; Chirkova T; Anderson LJ
Front Immunol; 2019; 10():1675. PubMed ID: 31402910
[TBL] [Abstract][Full Text] [Related]
6. In Hot Pursuit of the First Vaccine Against Respiratory Syncytial Virus.
Kim JY; Chang J
Yonsei Med J; 2016 Jul; 57(4):809-16. PubMed ID: 27189271
[TBL] [Abstract][Full Text] [Related]
7. Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults.
Green CA; Sande CJ; Scarselli E; Capone S; Vitelli A; Nicosia A; Silva-Reyes L; Thompson AJ; de Lara CM; Taylor KS; Haworth K; Hutchings CL; Cargill T; Angus B; Klenerman P; Pollard AJ
J Infect; 2019 May; 78(5):382-392. PubMed ID: 30742894
[TBL] [Abstract][Full Text] [Related]
8. Epicutaneous immunization using synthetic virus-like particles efficiently boosts protective immunity to respiratory syncytial virus.
Hervé PL; Dhelft V; Zuniga A; Ghasparian A; Rassek O; Yim KC; Donne N; Lambert PH; Benhamou PH; Sampson HA; Mondoulet L
Vaccine; 2021 Jul; 39(32):4555-4563. PubMed ID: 34154864
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B Virus Core Particles Containing a Conserved Region of the G Protein Combined with Interleukin-35 Protected Mice against Respiratory Syncytial Virus Infection without Vaccine-Enhanced Immunopathology.
Yang J; Ma C; Zhao Y; Fan A; Zou X; Pan Z
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321805
[TBL] [Abstract][Full Text] [Related]
10. Vaccination against respiratory syncytial virus in pregnancy: a suitable tool to combat global infant morbidity and mortality?
Saso A; Kampmann B
Lancet Infect Dis; 2016 Aug; 16(8):e153-63. PubMed ID: 27317449
[TBL] [Abstract][Full Text] [Related]
11. Host proteome correlates of vaccine-mediated enhanced disease in a mouse model of respiratory syncytial virus infection.
van Diepen A; Brand HK; de Waal L; Bijl M; Jong VL; Kuiken T; van Amerongen G; van den Ham HJ; Eijkemans MJ; Osterhaus AD; Hermans PW; Andeweg AC
J Virol; 2015 May; 89(9):5022-31. PubMed ID: 25694607
[TBL] [Abstract][Full Text] [Related]
12. Contribution of Dendritic Cells in Protective Immunity against Respiratory Syncytial Virus Infection.
Jung HE; Kim TH; Lee HK
Viruses; 2020 Jan; 12(1):. PubMed ID: 31952261
[TBL] [Abstract][Full Text] [Related]
13. Respiratory syncytial virus vaccine: where are we now and what comes next?
Noor A; Krilov LR
Expert Opin Biol Ther; 2018 Dec; 18(12):1247-1256. PubMed ID: 30426788
[TBL] [Abstract][Full Text] [Related]
14. Respiratory syncytial virus bronchiolitis : current and future strategies for treatment and prophylaxis.
Chávez-Bueno S; Mejías A; Welliver RC
Treat Respir Med; 2006; 5(6):483-94. PubMed ID: 17154675
[TBL] [Abstract][Full Text] [Related]
15. Receptors for Respiratory Syncytial Virus Infection and Host Factors Regulating the Life Cycle of Respiratory Syncytial Virus.
Feng Z; Xu L; Xie Z
Front Cell Infect Microbiol; 2022; 12():858629. PubMed ID: 35281439
[TBL] [Abstract][Full Text] [Related]
16. Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses.
Wang D; Bayliss S; Meads C
Health Technol Assess; 2011 Jan; 15(5):iii-iv, 1-124. PubMed ID: 21281564
[TBL] [Abstract][Full Text] [Related]
17. Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis.
Jacque E; Chottin C; Laubreton D; Nogre M; Ferret C; de Marcos S; Baptista L; Drajac C; Mondon P; De Romeuf C; Rameix-Welti MA; Eléouët JF; Chtourou S; Riffault S; Perret G; Descamps D
Front Immunol; 2021; 12():683902. PubMed ID: 34163482
[TBL] [Abstract][Full Text] [Related]
18. Imiquimod suppresses respiratory syncytial virus (RSV) replication via PKA pathway and reduces RSV induced-inflammation and viral load in mice lungs.
Salinas FM; Nebreda AD; Vázquez L; Gentilini MV; Marini V; Benedetti M; Nabaes Jodar MS; Viegas M; Shayo C; Bueno CA
Antiviral Res; 2020 Jul; 179():104817. PubMed ID: 32387475
[TBL] [Abstract][Full Text] [Related]
19. Antibody and Local Cytokine Response to Respiratory Syncytial Virus Infection in Community-Dwelling Older Adults.
Yu X; Lakerveld AJ; Imholz S; Hendriks M; Ten Brink SCA; Mulder HL; de Haan K; Schepp RM; Luytjes W; de Jong MD; van Beek J; van Kasteren PB
mSphere; 2020 Sep; 5(5):. PubMed ID: 32878928
[TBL] [Abstract][Full Text] [Related]
20. Mucosal vaccines against respiratory syncytial virus.
Yang K; Varga SM
Curr Opin Virol; 2014 Jun; 6():78-84. PubMed ID: 24794644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
